-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Sangamo Therapeutics, Inc quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2015 to Q2 2025.
- Sangamo Therapeutics, Inc Income Tax Expense (Benefit) for the quarter ending June 30, 2025 was $27K, a 63.5% decline year-over-year.
- Sangamo Therapeutics, Inc Income Tax Expense (Benefit) for the twelve months ending June 30, 2025 was -$193K, a 116% decline year-over-year.
- Sangamo Therapeutics, Inc annual Income Tax Expense (Benefit) for 2024 was -$167K, a 96.7% increase from 2023.
- Sangamo Therapeutics, Inc annual Income Tax Expense (Benefit) for 2023 was -$5.07M, a 1282% decline from 2022.
- Sangamo Therapeutics, Inc annual Income Tax Expense (Benefit) for 2022 was $429K, a 40.2% increase from 2021.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)